At ATTD 2026, Dexcom (Nasdaq:DXCM) outlined a range of ways in which its continuous glucose monitors (CGMs) benefit people ...

Dexcom’s Stelo continuous glucose monitor (CGM) for those with Type 2 diabetes is starting to use generative AI to write weekly reports with “more personalized tips, recommendations, and education ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of ...